Abstract
We are at a critical juncture in our knowledge of the etiology and pathogenesis of Parkinson disease (PD). It is clear that PD is not a single entity simply resulting from a dopaminergic deficit; rather it is most likely caused by a combination of genetic and environmental factors. Although there is extensive new information on the etiology and pathogenesis of PD, which may advance its treatment, new syntheses of this information are needed. The second part of this two-part, state-of-the-art review by leaders in PD research critically examines the research field to identify areas for which new knowledge and ideas might be helpful for treatment purposes. Topics reviewed in Part II are genetics, animal models, and oxidative stress.
Original language | English (US) |
---|---|
Pages (from-to) | 329-336 |
Number of pages | 8 |
Journal | Journal of neuropathology and experimental neurology |
Volume | 66 |
Issue number | 5 |
DOIs | |
State | Published - May 2007 |
Keywords
- Lewy bodies
- Parkinson disease
- Synucleinopathies
ASJC Scopus subject areas
- Pathology and Forensic Medicine
- Neurology
- Clinical Neurology
- Cellular and Molecular Neuroscience